Prostate Cancer - Results from #100

Meeting Aerobic Physical Activity Guidelines and Associations With Physical Fitness in Men With Metastatic Prostate Cancer: Baseline Results of the Multicentre INTERVAL-GAP4 Trial. December 6, 2024

Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020. December 6, 2024

Irish Prostate Cancer Outcomes Research (IPCOR) registry: cohort profile. December 5, 2024

Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects. December 5, 2024

In-field prostate cancer recurrence following radical prostatectomy and salvage radiation. December 5, 2024

Testing BRCA 1-2 Mutations in Metastatic Prostate Cancer: Results of a Survey of the Italian Association of Medical Oncology. December 5, 2024

Transperineal 3D fusion imaging-guided targeted microwaves ablation for low to intermediate-risk prostate cancer: results of a phase I-II study. December 5, 2024

Impact of androgen deprivation therapy in patients with unfavorable intermediate-risk prostate cancer receiving brachytherapy-based dose-escalated radiation therapy. December 5, 2024

Whole-gland or Subtotal High-intensity Focused Ultrasound Versus Radical Prostatectomy: The Prospective, Noninferiority, Nonrandomized HIFI Trial December 4, 2024

Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer December 4, 2024

First 2 Participants Dosed with Cu-64 SAR-bisPSMA in Co-PSMA Trial December 4, 2024

Safety of PSMA radioligand therapy in mCRPC patients with preexisting moderate to severe thrombocytopenia. December 4, 2024

Intratumoral heterogeneity drives acquired therapy resistance in a patient with metastatic prostate cancer. December 4, 2024

Surgical and oncological outcomes of salvage radical prostatectomy after focal therapies: a matched-pair analysis. December 4, 2024

Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients. December 4, 2024

Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024. December 4, 2024

Prostate cancer in people with HIV. December 4, 2024

Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review. December 4, 2024

Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment. December 3, 2024

ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer. December 3, 2024

Page 6 of 1448